NUWE (Nuwellis, Inc. Common Stock) Stock Analysis - SEC Filings

Nuwellis, Inc. Common Stock (NUWE) is a publicly traded ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector company. As of May 21, 2026, NUWE trades at $0.98 with a market cap of $2.58M and a P/E ratio of -0.04. NUWE moved +0.00% today. Year to date, NUWE is -49.26%; over the trailing twelve months it is -97.54%. Its 52-week range spans $0.90 to $175.98. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces NUWE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find NUWE SEC filings?

Rallies organizes NUWE SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

NUWE Key Metrics

Key financial metrics for NUWE
MetricValue
Price$0.98
Market Cap$2.58M
P/E Ratio-0.04
EPS$-25.39
Dividend Yield0.00%
52-Week High$175.98
52-Week Low$0.90
Volume4.87K
Avg Volume0
Revenue (TTM)$8.27M
Net Income$-17.52M
Gross Margin61.96%

Latest NUWE News

Recent NUWE Insider Trades

  • Jaramillo Nestor Jr. bought 4.10K (~$19.63K) on Mar 15, 2023.

NUWE Analyst Consensus

1 analysts cover NUWE: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.

Common questions about NUWE

Where can I find NUWE SEC filings?
Rallies organizes NUWE SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show NUWE 10-K and 10-Q filings?
Rallies organizes NUWE SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is NUWE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NUWE. It does not provide personalized investment advice.
NUWE

NUWE